Forty years of chromoblastomycosis in Madagascar: A review

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 1, 1996, Pages 45-47

  Esterre, Philippe ^a   Andriantsimahavandy, Abel ^a   Ramarcel, Estera Ramanantsoa ^a   Pecarrere, Jean Louis ^a  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

Author keywords

[No Author keywords available]

Indexed keywords

FONSECAEA PEDROSOI;

ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE; TIABENDAZOLE;

CHROMOMYCOSIS; CLINICAL TRIAL; ECOSYSTEM; ENDEMIC DISEASE; HUMAN; HUMAN TISSUE; LIVER TOXICITY; MADAGASCAR; MAJOR CLINICAL STUDY; MULTICENTER STUDY; REVIEW; TROPIC CLIMATE;

CHROMOBLASTOMYCOSIS; CLINICAL TRIALS; ECOLOGY; FEMALE; HUMANS; MADAGASCAR; MALE; MITOSPORIC FUNGI; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 0029680778     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.45     Document Type: Review

References (22)

1. Chaperon P, Danloux J, Ferry L, 1993. Fleuves et Rivieres de Madagascar. Bondy, France: ORSTOM.
2. Preston-Mafham K, 1991. Madagascar, A Natural History. New York: Facts on Files, Inc.
3. Coulanges P, 1971. La chromoblastomycose. Arch Inst Pasteur Madagascar 40: 63-84.
4. Brygoo ER, Segretain G, 1960. Etude clinique, epidimiologique et mycologique de la chromoblastomycose a Madagascar. Bull Soc Pathol Exot 3: 443-475.
5. Esterre P, Peyrol S, Guerret S, Sainte-Marie D, Pradinaud R, Grimaud JA, 1992. Cell-matrix patterns in the cutaneous lesion of chromomycosis. Pathol Res Pract 188: 894-900.
6. Esterre P, Peyrol S, Sainte-Marie D, Pradinaud R, Grimaud JA, 1993. Granulomatous reaction and tissue remodelling in the cutaneous lesion of chromomycosis. Virchows Arch 422: 285-291.
7. Esterre P, Lortat-Jacob H, Sainte-Marie D, Pradinaud R, Grimaud JA, 1994. The potential role of cytokines in the immunopathology of chromomycosis. An in situ immunohistochemical study in humans. J Mycol Med 4: 145-148.
8. Ricard-Blum S, Esterre P, Grimaud JA, 1993. Collagen cross-linking by pyridinoline occurs in non-reversible skin flbrosis. Cell Mol Biol 139: 723-727.
9. Coulanges P, Locheron P, 1981. La chromomycose a Madagascar: donnies epidemiologiques sur le foyer le plus imortant connu dans le monde (a propos de 891 cas diagnostiques de 1955 a 1978). Arch Inst Pasteur Madagascar 48: 69-95.
10. Salfelder K, 1990. Chromoblastomycosis. Salfelder K, Liscano TR, Sauerteig E, eds. Atlas of Fungal Pathology, Current Histopathology. Volume 17. Dordrecht, The Netherlands: Kluwer Academic Publishers, 145-150.
11. Espinel-Ingroff A, Shadomy S, Dixon D, Goldson P, 1986. Exoantigen test for Cladosporium bantianum, Fonsecaea pedrosoi and Phialophora verrucosa. Clin Microbiol 23: 305-310.
12. Ibrahim-Granet O, De Bievre C, Jendoubi J, 1988. Immunochemical characterisation of antigens and growth inhibition of Fonsecaea pedrosoi by species-specific IgG. J Med Microbiol 26: 217-222.
13. Andriantsimahavandy A, Michel P, Rasolofonirina N, Roux J, 1993. Apport de l'immunologie au diagnostic de ca Chromomycose a Madagascar. J Mycol Med 3: 30-36.
14. Bourdiec FL, 1974. Hommes et paysages du riz a Madagascar. Etude de Human Geographie Humaine. Antananarivo, Madagascar: FTM Publishers.
15. Michel P, Andriantsimahavandy A, Le Jeannic P, Ratsioharana M, Coulanges P, 1992. La chromomycose a Madagascar. Med Armees 20: 171-175.
16. Laporte P, 1990. La chromomycose dans l'ile de Mayotte (Comores). Med Trop (Mars) 2: 195-196.
17. Miquel P, 1978. Trois observations de chromoblastomycose a La Reunion. Med Mal Infect 8: 398-403.
18. Paul C, Dupont B, Pialoux G, Avril MF, Pradinaud R, 1991. Chromoblastomycosis with malignant transformation and cutaneous-synovial secondary localization. The potential therapeutic role of itraconazole. J Med Vet Mycol 29: 313-316.
19. Bayles MAH, 1971. Chromomycosis: treatment with thiabendazole. Arch Dermatol 104: 476-485.
20. Tuffanelli L, Mibum PB, 1990. Treatment of chromoblastomycosis. J Am Acad Dermatol 23: 728-732.
21. Restrepo A, Gonzalez A, Gomez I, 1988. Treatment of chromoblastomycosis with itraconazole. Ann NY Acad Sci 544: 504-516.
22. Schuster I, Schaude M, Schatz M, Mieth H, 1988. Preclinical characteristics of allylamines. Berg D, Plempel M, eds. Sterol Biosynthesis Inhibitors. Chichester, United Kingdom: Horwood Publishers, 449-470.